{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T12:08:25Z","timestamp":1795090105473,"version":"4.10.2"},"reference-count":69,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"am","delay-in-days":343,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes &amp; Metabolism"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.diabet.2024.101600","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T19:48:14Z","timestamp":1733514494000},"page":"101600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Skin autofluorescence of advanced glycation end-products, glycemic memory, and diabetes complications"],"prefix":"10.1016","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5175-6479","authenticated-orcid":false,"given":"Vincent","family":"Rigalleau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Pucheux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Couffinhal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic J","family":"Tessier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Howsam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Helmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi","family":"Alkhami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Larroumet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Am\u00e9lie","family":"Barbet-Massin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Ferriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamel","family":"Mohammedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninon","family":"Foussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabet.2024.101600_bib0001","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S2213-8587(21)00288-6","article-title":"Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records","volume":"10","author":"Pearson-Stuttard","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.diabet.2024.101600_bib0002","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jdiacomp.2009.07.001","article-title":"Impact of comorbid conditions and race\/ethnicity on glycemic control among the US population with type 2 diabetes, 1988-1994 to 1999-2004","volume":"24","author":"Suh","year":"2010","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.diabet.2024.101600_bib0003","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1001\/jamacardio.2017.4191","article-title":"Coronary artery calcium score for long-term risk classification in individuals with type 2 diabetes and metabolic syndrome from the multi-ethnic study of atherosclerosis","volume":"2","author":"Malik","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.diabet.2024.101600_bib0004","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1007\/s00125-004-1451-2","article-title":"Simple non-invasive assessment of advanced glycation endproduct accumulation","volume":"47","author":"Meerwaldt","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2024.101600_bib0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s00125-018-4769-x","article-title":"Skin autofluorescence predicts incident type 2 diabetes, cardiovascular disease and mortality in the general population","volume":"62","author":"van Waateringe","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2024.101600_bib0006","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.diabet.2024.101600_bib0007","doi-asserted-by":"crossref","first-page":"20796","DOI":"10.1074\/jbc.274.30.20796","article-title":"Structure and mechanism of formation of human lens fluorophore LM-1. Relationship to vesperlysine A and the advanced Maillard reaction in aging, diabetes, and cataractogenesis","volume":"274","author":"Tessier","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.diabet.2024.101600_bib0008","doi-asserted-by":"crossref","first-page":"870","DOI":"10.2337\/diabetes.48.4.870","volume":"48","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2024.101600_bib0009","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.2337\/diabetes.54.11.3103","volume":"54","author":"Genuth","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2024.101600_bib0010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.2337\/db14-0215","article-title":"Skin advanced glycation end products glucosepane and methylglyoxal hydroimidazolone are independently associated with long-term microvascular complication progression of type 1 diabetes","volume":"64","author":"Genuth","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2024.101600_bib0011","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12933-015-0266-4","article-title":"Skin collagen advanced glycation endproducts (AGEs) and the long-term progression of sub-clinical cardiovascular disease in type 1 diabetes","volume":"14","author":"Monnier","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2024.101600_bib0012","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2337\/dc18-0159","article-title":"Higher plasma methylglyoxal levels are associated with incident cardiovascular disease and mortality in individuals with type 2 diabetes","volume":"41","author":"Hansssen","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2024.101600_bib0013","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1042\/CS20220099","article-title":"Methylglyoxal and glyoxalase 1 \u2013 a metabolic stress pathway linking hyperglycemia to the unfolded protein response and vascular complications of diabetes","volume":"136","author":"Rabbani","year":"2022","journal-title":"Clin Sci"},{"key":"10.1016\/j.diabet.2024.101600_bib0014","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s41419-020-2602-1","article-title":"Molecular mechanisms of methylglyoxal-induced aortic endothelial dysfunction in human vascular endothelial cells","volume":"11","author":"Lee","year":"2020","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.diabet.2024.101600_bib0015","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.2337\/dc12-1077","article-title":"Skin autofluorescence reflects integration of past long-term glycemic control in patients with type 1 diabetes","volume":"36","author":"Sugisawa","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2024.101600_bib0016","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.diabet.2013.03.003","article-title":"Skin autofluorescence is associated with past glycaemic control and complications in type 1 diabetes mellitus","volume":"39","author":"Genevieve","year":"2013","journal-title":"Diabetes Metab"},{"issue":"1","key":"10.1016\/j.diabet.2024.101600_bib0017","first-page":"00038","article-title":"Skin autofluorescence, a marker of glucose memory in type 2 diabetes","volume":"7","author":"Rigo","year":"2020","journal-title":"Metabol Open"},{"key":"10.1016\/j.diabet.2024.101600_bib0018","article-title":"Progression of skin autofluorescence of AGEs over 4 years in patients with type 1 diabetes","volume":"33","author":"Rajaobelina","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabet.2024.101600_bib0019","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1177\/193229680800200407","article-title":"Skin advanced glycation end product accumulation is poorly reflected by glycemic control in type 2 diabetic patients (ZODIAC-9)","volume":"2","author":"Gerrits","year":"2008","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.diabet.2024.101600_bib0020","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1111\/dme.12803","article-title":"Is skin autofluorescence a marker of metabolic memory in pregnant women with diabetes?","volume":"32","author":"Maury","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/j.diabet.2024.101600_bib0021","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.2337\/dc22-0980","article-title":"The fast-glycator phenotype, skin advanced glycation end products, and complication burden among people with type 1 diabetes","volume":"45","author":"Maran","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2024.101600_bib0022","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13054-017-1598-0","article-title":"Skin autofluorescence in acute kidney injury","volume":"21","author":"Lavielle","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.diabet.2024.101600_bib0023","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.1046\/j.1523-1755.2001.59780058.x","article-title":"Circulating advanced glycation end product levels in rats rapidly increase with acute renal failure","volume":"78","author":"Sebekov\u00e1","year":"2001","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.diabet.2024.101600_bib0024","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000355692","article-title":"Tissue advanced glycation end product deposition after kidney transplantation","volume":"124","author":"Crowley","year":"2013","journal-title":"Nephron Clin Pr"},{"key":"10.1016\/j.diabet.2024.101600_bib0025","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/gerona\/glu243","article-title":"Autofluorescence of skin advanced glycation end products: marker of metabolic memory in elderly population","volume":"70","author":"Rajaobelina","year":"2015","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.diabet.2024.101600_bib0026","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1016\/j.numecd.2022.08.009","article-title":"Skin autofluorescence of advanced glycation end-products and mortality in older adults: the roles of chronic kidney disease and diabetes","volume":"32","author":"Majchrzak","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.diabet.2024.101600_bib0027","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/dia.2009.0113","article-title":"Reference values of skin autofluorescence","volume":"12","author":"Koetsier","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/j.diabet.2024.101600_bib0028","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/ajcn\/nqaa117","article-title":"The association between dietary and skin advanced glycation end products: the Rotterdam Study","volume":"112","author":"Chen","year":"2020","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.diabet.2024.101600_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0179330","article-title":"The association between various smoking behaviors, cotinine biomarkers and skin autofluorescence, a marker for advanced glycation end product accumulation","volume":"12","author":"van Waateringe","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.diabet.2024.101600_bib0030","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1007\/s00125-014-3286-9","article-title":"GWAS identifies an NAT2 acetylator status tag single nucleotide polymorphism to be a major locus for skin fluorescence","volume":"57","author":"Eny","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2024.101600_bib0031","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/dc07-1755","article-title":"Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications","volume":"31","author":"Gerrits","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2024.101600_bib0032","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.jdiacomp.2016.10.028","article-title":"Skin autofluorescence, renal insufficiency and retinopathy in patients with type 2 diabetes","volume":"31","author":"Bentata","year":"2017","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.diabet.2024.101600_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2020.03.005","article-title":"Diabetic retinopathy in well-controlled type 2 diabetes: role of glycaemic memory","volume":"47","author":"Ducos","year":"2021","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2024.101600_bib0034","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12933-016-0448-8","article-title":"Skin autofluorescence predicts cardio-renal outcome in type 1 diabetes: a longitudinal study","volume":"15","author":"V\u00e9layoudom-C\u00e9phise","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2024.101600_bib0035","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.numecd.2021.10.007","article-title":"Skin autofluorescence is associated with progression of kidney disease in type 2 diabetes: a prospective cohort study from the Hong Kong diabetes biobank","volume":"32","author":"Jin","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.diabet.2024.101600_bib0036","doi-asserted-by":"crossref","first-page":"e83799","DOI":"10.1371\/journal.pone.0083799","article-title":"Skin autofluorescence is associated with the progression of chronic kidney disease: a prospective observational study","volume":"8","author":"Tanaka","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.diabet.2024.101600_bib0037","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00125-005-1828-x","article-title":"Increased accumulation of skin advanced glycation end-products precedes and correlates with clinical manifestation of diabetic neuropathy","volume":"48","author":"Meerwaldt","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2024.101600_bib0038","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.2337\/dc10-1791","article-title":"Skin intrinsic fluorescence correlates with autonomic and distal symmetrical polyneuropathy in individuals with type 1 diabetes","volume":"34","author":"Conway","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2024.101600_bib0039","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2832","article-title":"Skin autofluorescence and peripheral neuropathy four years later in type 1 diabetes","volume":"33","author":"Rajaobelina","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.diabet.2024.101600_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107808","article-title":"For diabetic type 1 patients, the skin autofluorescence predicts ulcers and amputations","volume":"35","author":"Rojubally","year":"2021","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.diabet.2024.101600_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2023.108595","article-title":"The skin autofluorescence of advanced glycation end-products relates to the development of foot ulcers in type 2 diabetes: a longitudinal observational study","volume":"37","author":"Borderie","year":"2023","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.diabet.2024.101600_bib0042","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2337\/dc06-1391","article-title":"Skin autofluorescence is a strong predictor of cardiac mortality in diabetes","volume":"30","author":"Meerwaldt","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabet.2024.101600_bib0043","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1007\/s00125-009-1308-9","article-title":"Skin autofluorescence provides additional information to the UK Prospective Diabetes Study (UKPDS) risk score for the estimation of cardiovascular prognosis in type 2 diabetes mellitus","volume":"52","author":"Lutgers","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2024.101600_bib0044","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12933-018-0718-8","article-title":"Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study","volume":"17","author":"Blanc-Bisson","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2024.101600_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2024.101524","article-title":"Skin autofluorescence of advanced glycation end-products relates to new cardiovascular events in type 2 diabetes: a longitudinal observational study","volume":"50","author":"Alkhami","year":"2024","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2024.101600_bib0046","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/s12933-023-02052-7","article-title":"Advanced glycation end products measured by skin autofluorescence and subclinical cardiovascular disease: the Rotterdam Study","volume":"22","author":"Chen","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2024.101600_bib0047","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12933-024-02121-5","article-title":"The skin autofluorescence may help to select patients with Type 2 diabetes candidates for screening to revascularization procedures","volume":"23","author":"Alkhami","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2024.101600_bib0048","doi-asserted-by":"crossref","first-page":"316","DOI":"10.5551\/jat.64293","article-title":"Skin autofluorescence and clinical outcomes in patients with coronary artery disease","volume":"31","author":"Kawamoto","year":"2024","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.diabet.2024.101600_bib0049","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00125-022-05821-3","article-title":"Advanced glycation end-products, cardiac function and heart failure in the general population: the Rotterdam Study","volume":"66","author":"Arshi","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.diabet.2024.101600_bib0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2021.101273","article-title":"Skin autofluorescence predicts mortality in type 1 diabetes","volume":"48","author":"Larroumet","year":"2022","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2024.101600_bib0051","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001312","article-title":"Skin autofluorescence predicts cancer in subjects with type 2 diabetes","volume":"9","author":"Foussard","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/j.diabet.2024.101600_bib0052","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.diabres.2019.01.002","article-title":"Methylglyoxal, a potent inducer of AGEs, connects between diabetes and cancer","volume":"148","author":"Bellier","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabet.2024.101600_bib0053","doi-asserted-by":"crossref","first-page":"19967","DOI":"10.1038\/s41598-024-71037-7","article-title":"Skin autofluorescence and cause-specific mortality in a population-based cohort","volume":"14","author":"Boersma","year":"2024","journal-title":"Scientific Rep"},{"key":"10.1016\/j.diabet.2024.101600_bib0054","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1038\/s41598-024-51703-6","article-title":"Skin autofluorescence, reflecting accumulation of advanced glycation end products, and the risk of dementia in a population-based cohort","volume":"14","author":"Mooldijk","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.diabet.2024.101600_bib0055","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1210\/jc.2014-2754","article-title":"Associations of advanced glycation end-products with cognitive functions in individuals with and without type 2 diabetes: the maastricht study","volume":"100","author":"Spauwen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.diabet.2024.101600_bib0056","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jpsychires.2013.03.016","article-title":"Increased advanced glycation end-products (AGEs) assessed by skin autofluorescence in schizophrenia","volume":"47","author":"Kouidrat","year":"2013","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.diabet.2024.101600_bib0057","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.jhep.2010.10.012","article-title":"Skin autofluorescence is high in patients with cirrhosis - further arguing for the implication of Advanced Glycation End products","volume":"54","author":"Maury","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.diabet.2024.101600_bib0058","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.3390\/jcm11185341","article-title":"Skin autofluorescence measurement as initial assessment of hepatic parenchyma quality in patients undergoing liver resection","volume":"11","author":"Krasnod\u0119bski","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.diabet.2024.101600_bib0059","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/db18-0906","article-title":"Skin autofluorescence of pregnant women with diabetes predicts the macrosomia of their children","volume":"68","author":"Foussard","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/j.diabet.2024.101600_bib0060","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabet.2017.10.014","article-title":"Standards for screening and surveillance of ocular complications in people with diabetes SFD study group.Early worsening of diabetic retinopathy after rapid improvement of blood glucose control in patients with diabetes","volume":"44","author":"Feldman-Billard","year":"2018","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2024.101600_bib0061","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.diabet.2024.101600_bib0062","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2022.108234","article-title":"Cardiovascular events after a dramatic reduction of HbA1c in hospitalized subjects with type 2 diabetes and high long-term glucose exposure","volume":"36","author":"Rigalleau","year":"2022","journal-title":"J Diabetes Complicat"},{"key":"10.1016\/j.diabet.2024.101600_bib0063","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1159\/000506136","article-title":"Trends in the use of eye care services in adults treated for diabetes between 2008 and 2017 in France: a nationwide study","volume":"63","author":"Cougnard-Gr\u00e9goire","year":"2020","journal-title":"Ophthalmic Res"},{"key":"10.1016\/j.diabet.2024.101600_bib0064","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101498","article-title":"Low frequency of albuminuria testing among diabetic patients in France: real-world data from clinical laboratories","volume":"50","author":"Bonnet","year":"2024","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabet.2024.101600_bib0065","doi-asserted-by":"crossref","first-page":"bvad073","DOI":"10.1210\/jendso\/bvad073","article-title":"Comparison of endocrinologists' physical examination documentation for in-person vs video telehealth diabetes visits","volume":"7","author":"Arao","year":"2023","journal-title":"J Endocr Soc"},{"key":"10.1016\/j.diabet.2024.101600_bib0066","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2017036","article-title":"Cancer screening rate in people with diabetes in the Korean population: results from the Korea National Health and Nutrition Examination Survey 2007-2009","volume":"39","author":"Chuck","year":"2017","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.diabet.2024.101600_bib0067","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12933-021-01253-2","article-title":"Cost-effectiveness of screening of coronary artery disease in patients with type 2 DIABetes at a very high cardiovascular risk (SCADIAB study) rational and design","volume":"20","author":"Mohammedi","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.diabet.2024.101600_bib0068","doi-asserted-by":"crossref","first-page":"e05364","DOI":"10.1016\/j.heliyon.2020.e05364","article-title":"Is skin autofluorescence (SAF) representative of dermal advanced glycation endproducts (AGEs) in dark skin? A pilot study","volume":"6","author":"Atzeni","year":"2020","journal-title":"Heliyon"},{"key":"10.1016\/j.diabet.2024.101600_bib0069","doi-asserted-by":"crossref","first-page":"e14499","DOI":"10.1111\/dme.14499","article-title":"Can the skin autofluorescence predict retinopathy in diabetes?","volume":"38","author":"Rigalleau","year":"2021","journal-title":"Diabet Med"}],"container-title":["Diabetes &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363624000910?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1262363624000910?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T17:00:07Z","timestamp":1738688407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1262363624000910"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1262363624000910"],"URL":"https:\/\/doi.org\/10.1016\/j.diabet.2024.101600","relation":{},"ISSN":["1262-3636"],"issn-type":[{"value":"1262-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin autofluorescence of advanced glycation end-products, glycemic memory, and diabetes complications","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabet.2024.101600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101600"}}